Exosomes/Extracellular Vesicles
Category: Cell Therapy and Regenerative Medicine
Exhibitor: TRANSWELL BIOTECH CO., LTD.
Booth No: M626
Characteristic
TRANSWELL BIOTECH CO., LTD. is dedicated to developing technologies for the isolation, purification, and lyophilization of extracellular vesicles (EVs) and exosomes. The sources of these EVs and exosomes include chicken embryonic cells, human dermal fibroblasts, and human umbilical cord mesenchymal stem cells. Analysis and quantification are conducted using nanoparticle tracking analysis (NTA).
Cell and animal experiments have demonstrated that the EVs and exosomes produced by our company can promote the proliferation of dermal fibroblasts and dermal papilla cells, enhance collagen secretion by dermal fibroblasts, reduce damage caused by free radicals and oxidative stress, inhibit immune cells, improve lung fibrosis and enhance lung function in mice. The EVs and exosomes developed by TRANSWELL BIOTECH CO., LTD. are intended for use in new drug development and as ingredients in cosmetic and skincare products.
Other Products
Products you may be interested in
Highest Rated Products